Stable Gastric Pentadecapeptide BPC 157: Prompt Particular Activation of Collateral Pathways
- PMID: 36200148
- DOI: 10.2174/0929867329666221005111553
Stable Gastric Pentadecapeptide BPC 157: Prompt Particular Activation of Collateral Pathways
Similar articles
-
Gastric pentadecapeptide BPC 157 effective against serotonin syndrome in rats.Eur J Pharmacol. 2005 Apr 11;512(2-3):173-9. doi: 10.1016/j.ejphar.2005.02.033. Eur J Pharmacol. 2005. PMID: 15840402
-
Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights.World J Gastroenterol. 2017 Dec 28;23(48):8465-8488. doi: 10.3748/wjg.v23.i48.8465. World J Gastroenterol. 2017. PMID: 29358856 Free PMC article.
-
Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia). Full and distended stomach, and vascular response.Inflammopharmacology. 2006 Dec;14(5-6):214-21. doi: 10.1007/s10787-006-1531-7. Inflammopharmacology. 2006. PMID: 17186181 Review.
-
Therapy of the rat hemorrhagic cystitis induced by cyclophosphamide. Stable gastric pentadecapeptide BPC 157, L-arginine, L-NAME.Eur J Pharmacol. 2019 Oct 15;861:172593. doi: 10.1016/j.ejphar.2019.172593. Epub 2019 Aug 8. Eur J Pharmacol. 2019. PMID: 31401154
-
Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157.Curr Pharm Des. 2013;19(1):76-83. doi: 10.2174/13816128130111. Curr Pharm Des. 2013. PMID: 22950504 Review.
Cited by
-
New studies with stable gastric pentadecapeptide protecting gastrointestinal tract. significance of counteraction of vascular and multiorgan failure of occlusion/occlusion-like syndrome in cytoprotection/organoprotection.Inflammopharmacology. 2024 Oct;32(5):3119-3161. doi: 10.1007/s10787-024-01499-8. Epub 2024 Jul 9. Inflammopharmacology. 2024. PMID: 38980576 Review.
-
Antiarrhythmic Sotalol, Occlusion/Occlusion-like Syndrome in Rats, and Stable Gastric Pentadecapeptide BPC 157 Therapy.Pharmaceuticals (Basel). 2023 Jul 7;16(7):977. doi: 10.3390/ph16070977. Pharmaceuticals (Basel). 2023. PMID: 37513889 Free PMC article.
-
Stomach perforation-induced general occlusion/occlusion-like syndrome and stable gastric pentadecapeptide BPC 157 therapy effect.World J Gastroenterol. 2023 Jul 21;29(27):4289-4316. doi: 10.3748/wjg.v29.i27.4289. World J Gastroenterol. 2023. PMID: 37545637 Free PMC article.
-
Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System.Pharmaceuticals (Basel). 2025 Jun 19;18(6):928. doi: 10.3390/ph18060928. Pharmaceuticals (Basel). 2025. PMID: 40573323 Free PMC article. Review.
-
Pentadecapeptide BPC 157 as Therapy for Inferior Caval Vein Embolization: Recovery of Sodium Laurate-Post-Embolization Syndrome in Rats.Pharmaceuticals (Basel). 2023 Oct 23;16(10):1507. doi: 10.3390/ph16101507. Pharmaceuticals (Basel). 2023. PMID: 37895979 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources